Nasim Yousaf

812 total citations
29 papers, 655 citations indexed

About

Nasim Yousaf is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Nasim Yousaf has authored 29 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Genetics. Recurrent topics in Nasim Yousaf's work include Blood groups and transfusion (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Diabetes and associated disorders (5 papers). Nasim Yousaf is often cited by papers focused on Blood groups and transfusion (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Diabetes and associated disorders (5 papers). Nasim Yousaf collaborates with scholars based in United Kingdom, United States and Portugal. Nasim Yousaf's co-authors include Heimo Riedel, Youping Deng, Yuti Chernajovsky, Jonathan C. Howard, Bryan Williams, Youhou Kang, Hans Hansen, Huriya Beyan, Marco Londei and G. A. Hitman and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nasim Yousaf

29 papers receiving 635 citations

Peers

Countries citing papers authored by Nasim Yousaf

Since Specialization

Citations

This map shows the geographic impact of Nasim Yousaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasim Yousaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasim Yousaf more than expected).

Fields of papers citing papers by Nasim Yousaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasim Yousaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasim Yousaf. The network helps show where Nasim Yousaf may publish in the future.

Co-authorship network of co-authors of Nasim Yousaf

This figure shows the co-authorship network connecting the top 25 collaborators of Nasim Yousaf. A scholar is included among the top collaborators of Nasim Yousaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasim Yousaf. Nasim Yousaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Demonstrating Interactions of Transcription Factors with DNA by Electrophoretic Mobility Shift Assay 2017 ·Methods in molecular biology ·Nasim Yousaf, David Gould	1
2	Growth associated protein (GAP-43): Cloning and the development of a sensitive ELISA for neurological disorders 2014 ·Journal of Neuroimmunology ·Sharmilee Gnanapavan, Nasim Yousaf, Wendy Heywood, Donna Grant, Kevin Mills, Yuti Chernajovsky, Geoff Keir, Gavin Giovannoni	7
3	Differences between disease-associated endoplasmic reticulum aminopeptidase 1 (ERAP1) isoforms in cellular expression, interactions with tumour necrosis factor receptor 1 (TNF-R1) and regulation by cytokines 2014 ·Clinical & Experimental Immunology ·Nasim Yousaf, (unknown), Abiodun Onipinla, Charles A. Mein, Mark J. Caulfield, Patricia B. Munroe, Yuti Chernajovsky	8
4	A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Alexander Annenkov, (unknown), Sandra Amor, Dun Zhou, Nasim Yousaf, Bernhard Hemmer, Yuti Chernajovsky	3
5	Posttraumatic Activity of Signal Pathways of Nuclear Factor κB in Mature Sensory Neurons 2010 ·Bulletin of Experimental Biology and Medicine ·(unknown), Charalambos Magoulas, Nasim Yousaf, P. M. Richardson, (unknown)	1
6	Abnormal tumor necrosis factor receptor I cell surface expression and NF‐κB activation in tumor necrosis factor receptor–associated periodic syndrome 2007 ·Arthritis & Rheumatism ·Belinda Nedjai, G. A. Hitman, Nasim Yousaf, Yuti Chernajovsky, (unknown), Tom Pettersson, Annamari Ranki, Philip N. Hawkins, Peter D. Arkwright, Michael McDermott, Mark D. Turner	56
7	Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis 2007 ·Arthritis Research & Therapy ·David Gould, Nasim Yousaf, Rewas Fatah, (unknown), Yuti Chernajovsky	20
8	Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor–associated periodic syndrome interacts with wild‐type tumor necrosis factor receptor I and induces ligand‐independent NF‐κB activation 2005 ·Arthritis & Rheumatism ·Nasim Yousaf, David Gould, Ebun Aganna, L Hammond, Rita Mirakian, Mark D. Turner, G. A. Hitman, Michael McDermott, Yuti Chernajovsky	53
9	Effect of X‐ and Y‐Box Deletions on the Development of Diabetes in H‐2Eα‐Chain Transgenic Nonobese Diabetic Mice 2005 ·Scandinavian Journal of Immunology ·Helen O’Shea, Nasim Yousaf, Daniel M. Altmann, Zoltán Fehérvári, Paul Tonks, C. Hetherington, (unknown), (unknown), Anne Cooke, Torben Lund	2
10	Altered Isoform Switch in Monocyte Cox-1 and Cox-2 Response to Lipopolysaccharide in Type 1 Diabetes 2004 ·Clinical Science ·Huriya Beyan, Martin R. Goodier, Niga Nawroly, Mohammed I. Hawa, (unknown), Stephen A. Bustin, Nasim Yousaf, Marco Londei, Richard David Leslie	1
11	Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes 2003 ·Gene Therapy ·Lei Dai, A. Claxson, Stefan L. Marklund, Roger Feakins, Nasim Yousaf, Yuti Chernajovsky, Paul G. Winyard	42
12	A role for innate immunity in type 1 diabetes? 2002 ·Diabetes/Metabolism Research and Reviews ·Huriya Beyan, (unknown), Nasim Yousaf, Marco Londei, R. D. G. Leslie	50
13	Four PSM/SH2-B Alternative Splice Variants and Their Differential Roles in Mitogenesis 2001 ·Journal of Biological Chemistry ·Nasim Yousaf, Youping Deng, Youhou Kang, Heimo Riedel	62
14	Grb10, a Positive, Stimulatory Signaling Adapter in Platelet-Derived Growth Factor BB-, Insulin-Like Growth Factor I-, and Insulin-Mediated Mitogenesis 1999 ·Molecular and Cellular Biology ·Jian Wang, (unknown), Nasim Yousaf, Mustapha Moussaif, Youping Deng, (unknown), (unknown), (unknown), Heimo Riedel	93
15	Characterization of polymorphisms at the 11β‐hydroxylase (CYP11B1) locus 1998 ·Annals of Human Genetics ·(unknown), Nasim Yousaf, John W. Honour, Gill Rumsby	4
16	Mutations in the Vitamin D Receptor Gene in Three Kindreds Associated with Hereditary Vitamin D Resistant Rickets 1997 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), Nasim Yousaf, Martin Hewison, J. L. H. O’Riordan, S M Farrow	39
17	PSM, an Insulin-Dependent, Pro-Rich, PH, SH2 Domain Containing Partner of the Insulin Receptor 1997 ·The Journal of Biochemistry ·Heimo Riedel, (unknown), Hans Hansen, Nasim Yousaf	63
18	Complement‐dependent synergistic effects of rat monoclonal IgG antibodies in vivo 1993 ·European Journal of Immunology ·Nasim Yousaf, Jonathan C. Howard, Bryan Williams	2
19	Targeting behavior of rat monoclonal IgG antibodies in vivo: role of antibody isotype, specificity and the target cell antigen density 1991 ·European Journal of Immunology ·Nasim Yousaf, Jonathan C. Howard, Bryan Williams	11
20	Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. II. Effects of immune complex infusion. 1986 ·PubMed ·Nasim Yousaf, Jonathan C. Howard, Bryan Williams	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact